Age-related macular degeneration is a common cause of blindness, but adding some static noise to a patient’s vision can ...

Researchers have identified distinct biological features linked to a high risk of developing a severe form of age-related ...

D Molecular Therapeutics (NASDAQ:FDMT) executives said the company is seeing strong clinical trial momentum for its lead retinal gene therapy candidate, 4D-150, as it advances through late-stage devel ...

But when the retina is damaged, vision can slowly become blurred, distorted or permanently lost, often before a person even ...

An expert MD reveals clear insights into cataract surgery, spotlighting the breakthroughs in treatment: "We live in a time of miracle and wonder." The post “What I Wish I’d Known About Cataract ...

Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) reported first-quarter 2026 results and used its earnings call to highlight progress across its cell therapy pipeline, including its lead OpRegen program ...

According to the Centers for Disease Control and Prevention, an estimated 93 million American adults are at high risk for ...

REGENXBIO faces regulatory setbacks for its rare disease drugs, with cash extending only into early 2027. See why RGNX stock ...

An announcement from Harrow Health ( (HROW)) is now available. Harrow reported first-quarter 2026 results on May 11, 2026, highlighting strong demand across its ophthalmic portfolio despite lower ...

Startups have developed chips that allow people to control machines with their thoughts. Billionaires are betting these brain ...

Science fiction has long imagined a world where our brains interact with machines to restore and augment our abilities—think ...

Researchers have been working for decades on so-called brain-computer interfaces to help people who suffer from paralysis, ...